Capvaxive 0.5 ML syringe 0.5ML
Ended Awarded
- Contract number
- SPE2DB25FVKY2
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $17,481
Award facts
- Contract value 100% obligated
- $17,481.41 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Capvaxive 0.5 ML syringes. The contract, which is not set-aside and competitively awarded, carries a ceiling value of $17,481.41 under firm fixed pricing terms and is scheduled for completion by September 11, 2025. AmerisourceBergen will perform the work at its corporate office in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, leverages its prime indefinite delivery contract to fulfill DLA requirements across a broad spectrum of pharmaceutical products and medical supplies supporting military healthcare systems worldwide. The company's extensive federal contract portfolio demonstrates consistent capability to deliver specialty medications, vaccines, medical devices, and other critical healthcare commodities to government customers including the Defense Health Agency and U.S. Coast Guard. As DLA Troop Support moves toward establishing the next generation of Pharmaceutical Prime Vendor Global Program contracts, AmerisourceBergen's continued performance on this delivery order reflects its position as a qualified vendor within the federal medical supply chain.
Quick answers
Who was awarded contract SPE2DB25FVKY2?
SPE2DB25FVKY2 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 10, 2025.
How much is contract SPE2DB25FVKY2 worth?
The government has obligated $17,481 on SPE2DB25FVKY2.
Is contract SPE2DB25FVKY2 an order under another contract?
Yes. SPE2DB25FVKY2 is a delivery order under SPE2DB22D1202, an indefinite delivery contract.
Was contract SPE2DB25FVKY2 competed?
The extent of competition for SPE2DB25FVKY2 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award